Table 2B.
Characteristics of adjuvant treatment for patients diagnosed with ovarian cancer.
| Total N = 189 |
Group 1: Primary surgery at tertiary gyn-onc center N = 130 |
Group 2: Primary surgery at non-tertiary center N = 59 |
P-value | |
|---|---|---|---|---|
| Adjuvant treatment, N (%) No chemotherapy Adjuvant chemotherapy Neoadjuvant chemotherapy |
18 (9.5) 104 (55.0) 67 (35.4) |
11 (8.5) 82 (63.1) 37 (28.5) |
7 (11.9) 22 (37.3) 30 (50.8) |
.004 |
| Mean time from diagnosis until start of chemotherapy, days ± SD | 37.0 ± 24.6 | 33.3 ± 17.7 | 45.1 ± 34.3 | .005 |
| Mean time from completion of surgical cytoreduction until start of adjuvant chemotherapy, days ± SD | 37.2 ± 16.0 | 37.9 ± 16.6 | 34.9 ± 13.6 | .455 |
A statistically significant p-value lower than 0.05 is marked bold in the table.
N, number; SD, standard deviation; ml, milliliter.